Background: Preoperative evaluation of suspected ovarian malignancy is of paramount importance and a diagnostic tool with high degree of precision helps treating physician in planning appropriate surgery and also neoadjuvant chemo therapy in candidates who are not currently fit for extensive surgical procedure. Though the ultrasound examination of abdomen and pelvis helps one in detection and characterization of adnexal lesion to some extent, its diagnostic ability is further improved by addition of advanced imaging techniques such as computed tomography, magnetic resonance imaging and thus can prove beneficial in choosing patient for right surgery, there by optimising the treatment outcome. Objective of current study was to compare ultraso...
Purpose: The combination of two tumour markers, CA125 and HE4, in the risk of ovarian malignancy ass...
Objective: Ovarian cancer is a silent disease with few symptoms. Because early detection of ovarian ...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
Ovarian cancer is the most aggressive gynecologic malignancy, with a 5-year survival rate ranging ar...
Cancer of the ovary is the second most common gynaecological malignancy and is the 5th leading cause...
Objectives: The aim of the present study is to determine the predictive value of Computed Tomography...
Background: Aim of the study was to study demographic profile and diagnostic modalities of ovarian t...
Background: To differentiate ovarian mass as benign or malignant could change clinical approach. Fin...
Background: Initial therapy for ovarian carcinoma involves aggressive surgery to remove as much tumo...
Gynaecological malignancies are the most common malignancies in women and also an important public h...
Introduction: Ovarian tumor is a group of diseases that originates in the ovaries or in the related ...
To establish the diagnostic accuracy of CA-125 levels with ultrasonography to predict ovarian cancer...
Background: Preoperative discrimination between benign and malignant ovarian neoplasm is necessary t...
Background: Ovarian carcinoma is a silent killer because it presents in advanced stage. In India, it...
Purpose: The combination of two tumour markers, CA125 and HE4, in the risk of ovarian malignancy ass...
Objective: Ovarian cancer is a silent disease with few symptoms. Because early detection of ovarian ...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
Ovarian cancer is the most aggressive gynecologic malignancy, with a 5-year survival rate ranging ar...
Cancer of the ovary is the second most common gynaecological malignancy and is the 5th leading cause...
Objectives: The aim of the present study is to determine the predictive value of Computed Tomography...
Background: Aim of the study was to study demographic profile and diagnostic modalities of ovarian t...
Background: To differentiate ovarian mass as benign or malignant could change clinical approach. Fin...
Background: Initial therapy for ovarian carcinoma involves aggressive surgery to remove as much tumo...
Gynaecological malignancies are the most common malignancies in women and also an important public h...
Introduction: Ovarian tumor is a group of diseases that originates in the ovaries or in the related ...
To establish the diagnostic accuracy of CA-125 levels with ultrasonography to predict ovarian cancer...
Background: Preoperative discrimination between benign and malignant ovarian neoplasm is necessary t...
Background: Ovarian carcinoma is a silent killer because it presents in advanced stage. In India, it...
Purpose: The combination of two tumour markers, CA125 and HE4, in the risk of ovarian malignancy ass...
Objective: Ovarian cancer is a silent disease with few symptoms. Because early detection of ovarian ...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...